Related Experiment Video
Updated: Mar 21, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Trends in Survival and Short-Term Outcomes Among Preterm Infants Less Than 32 Weeks From 2016 to 2022: A
Fahad Butt1, Nisha Viji Varghese1, Javeria Bhatti1
1Neonatology, Tawam Hospital, Al Ain, ARE.
Insights
Survival rates for preterm infants under 32 weeks improved significantly. However, this increase in survival was linked to higher rates of bronchopulmonary dysplasia, periventricular leukomalacia, and sepsis in these vulnerable infants.
Area of Science:
- Neonatalogy
- Pediatric Outcomes
- Public Health
Background:
- Contemporary data on preterm infant outcomes are crucial for healthcare resource allocation and clinical decision-making.
- Understanding trends in survival and complications for infants born before 32 weeks gestational age is vital.
Purpose of the Study:
- To examine survival rates, in-hospital complications, and antenatal care practices for infants born before 32 weeks gestational age.
- To analyze trends in preterm infant outcomes over a seven-year period.
Main Methods:
- Retrospective cohort study of 700 infants born before 32 weeks gestational age admitted between January 2016 and December 2022.
- Data collection included demographics, survival to discharge, length of stay, and incidence of major morbidities.
- Comparison of outcomes between two periods: 2016-2019 and 2020-2022.
Main Results:
- Overall survival to discharge was 79% (553/700).
- Significant increases in bronchopulmonary dysplasia (BPD), periventricular leukomalacia (PVL), and late-onset sepsis were observed between the two study periods.
- While rates of retinopathy of prematurity (ROP) and necrotizing enterocolitis (NEC) needing treatment increased, these changes were not statistically significant. Severe intraventricular hemorrhage (IVH) showed a non-significant reduction.
Conclusions:
- A significant increase in survival for preterm infants (<32 weeks) was observed over the study period.
- Improved survival was associated with a significant rise in BPD, PVL, and sepsis rates.
- Further research is needed to mitigate the increased morbidities associated with improved survival in extremely preterm infants.
Abstract:
Introduction Contemporary data on preterm infant outcomes are vital for improving healthcare resources and results, as well as guiding professionals and families in counselling and decision-making. Objective To examine the survival rates, in-hospital complications, and antenatal care practices for infants born before 32 weeks of gestational age. Methods Demographics and outcome data were retrospectively gathered, adhering to standard definitions, for a cohort of infants born before 32 weeks of gestational age admitted between January 2016 and December 2022 at Tawam Hospital, UAE. Results Of the 700 infants with gestational ages 22+0 to 31+6, over the seven years, 553 (79%) survived to discharge. Overall, the median (IQR) length of stay in survivors was 67 (42, 95) days. Bronchopulmonary dysplasia (BPD) (any grade) was 228 (40.5%), and 89 (12.9%) preterm infants had necrotizing enterocolitis (NEC) stage 2 and above. Late-onset sepsis was seen in 195 (30.1%) cases. Regarding neurological injury, intraventricular hemorrhage (IVH) grade 3 and above was recorded in 57 (9.2%) cases, and periventricular leukomalacia (PVL) was noted in 37 (8.4%) infants. Patent ductus arteriosus (PDA) treatment was given to 115 (16.7%), and retinopathy of prematurity (ROP) treatment was needed in 8.5% of preterm infants. The study was divided into two periods: period 1 (2016-2019) and period 2 (2020-2022). Mortality was 92 (23.8%) in period 1 vs. 55 (17.6%) in period 2. Morbidities between period 1 vs. period 2 were as follows: BPD 101 (33.8%) vs. 127 (48.1%) (p < 0.0001), PVL 13 (5.7%) vs. 24 (11.2%) (p < 0.038), and sepsis 90 (25.5%) vs. 105 (35.6%) (p = 0.005). Rates of ROP needing treatment and NEC≥2, 18 (7.1%) vs. 23 (10%) and 45 (11.8%) vs. 44 (14.3%), respectively, p=0.239 and p=0.327, respectively, and severe IVH 34 (10%) vs. 23 (8%) (p=0.357). Conclusion A significant increase in survival in less than 32 weeks was noted over the study period. Increase in survival was associated with a notable rise in BPD, PVL, and sepsis. Rates of ROP needing treatment and NEC ≥ 2 increased, but the rise didn't reach statistical significance. On the other hand, a non-statistically significant reduction in severe IVH cases was observed.
Related Concept Videos
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Teratogenicity
Assumptions of Survival Analysis

